4:46 PM ET
10-Q
Financial Results
Creative Medical Technology Holdings Q3 2026 Results: Net Loss of $2.67M, Loss Widens
Creative Medical Technology Holdings reported a net loss of $5.59 million for the nine months ended September 30, 2026, driven by increased research and development and SG&A expenses. The company remains in a pre-revenue stage for the current period, though it successfully raised approximately $4.06 million through warrant exercises and stock sales to support its regenerative therapy pipeline.
- Key figure
- Net loss $2.67M